Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis0q
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Disease
6.1 Introduction
6.2 Prostate cancer
6.3 Lung cancer
6.4 Breast cancer
6.5 Cervical cancer
6.6 Colorectal cancer
Chapter 7 Market Segmentation by Application
7.1 Introduction
7.2 Risk assessment
7.2 Disease diagnostics
7.3 Development of Molecular Diagnostics
7.4 Drug formulation
7.5 Others
Chapter 8 Market Segmentation by Service
8.1 Introduction
8.2 Sample preparation
8.3 Assay development
8.4 Biomarkers validation and testing
Chapter 9 Market Segmentation by Type
9.1 Introduction
9.2 Protein biomarkers
9.3 Genetic biomarkers
9.4 Cell biomarkers
9.5 Viral Biomarkers
9.6 Carbohydrate biomarkers
Chapter 10 Market Segmentation by Technology
10.1 Introduction
10.2 Omics technologies
10.3 Cytogenetics
10.4 Imaging technologies
10.5 Immunoassays
10.6 Bioinformatics
10.7 IVD multivariate index assays
Chapter 11 Market Segmentation by Geography
11.1 North America
11.1.1 Introduction
11.1.2 United States
11.1.3 Canada
11.1.4 Mexico
11.1.5 Others
11.2 Europe
11.2.1 Introduction
11.2.2 France
11.2.3 Germany
11.2.4 Italy
11.2.5 United Kingdom
11.2.6 Spain
11.2.7 Russia
11.2.8 Others
11.3 Asia-pacific
11.3.1 Introduction
11.3.2 China
11.3.3 Japan
11.3.4 India
11.3.5 Australia
11.3.6 Others
11.5 Latin America
11.6.1 Introduction
11.6.2 Brazil
11.6.3 Argentina
11.6.4 Others
11.6 The Middle East and Africa
11.6.1 Introduction
11.6.2 Saudi Arabia
11.6.3 Israel
11.6.4 UAE
11.6.5 Others
Chapter 12 Competitive Landscape
12.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
12.2 Market Share Analysis
12.3 Strategies Adopted By Top Companies
Chapter 13 Company Profiles
13.1 AffymetrixInc
13.2 HologicInc
13.3 Abbott Laboratories
13.4 Roche Diagnostics Corp.
13.5 Agilent Technologies
13.6 Astex Pharmaceuticals
13.7 Gen-Probe Inc
13.8 Atossa Genetics
13.9 Ambry Genetics
13.10 Thermo Fisher Scientific
13.11 Becton, Dickinson and Company
13.12 Danaher Corporation
13.13 GE Healthcare
13.14 Quest Diagnostics
13.15 Myriad Genetics
13.16 Biomérieux SA
13.17 Bio-Rad Laboratories
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.42 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
